Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pi Xu Yi Hao Fang (脾虚一号方) is a traditional Chinese medicine (TCM) formula designed for the treatment of "spleen deficiency" syndrome, a concept in TCM characterized by symptoms such as poor appetite, fatigue, loose stools, and general digestive weakness. The formula is typically composed of multiple herbal ingredients selected to tonify the spleen, support digestion, and improve overall gastrointestinal function. Its mechanism of action is based on TCM theory rather than modern pharmacology; it aims to restore balance within the body's organ systems by strengthening spleen qi and harmonizing the digestive tract. There are no standardized or internationally recognized clinical trials for this formulation in Western medicine; its use remains primarily within TCM practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pi xu yi hao fang.